Malignant pleural effusions because of lung cancer
Author:
- 1 July 2016
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 22 (4) , 356-361
Abstract
The discovery of a pleural effusion in the setting of lung cancer has diagnostic, prognostic, and therapeutic challenges, some of which are addressed in this review. Around 20% of patients with lung cancer have minimal pleural effusions, which are not amenable to a diagnostic thoracentesis. These patients have a poorer overall survival (∼7.5 months) than those without effusions (∼12-18 months), although slightly better than those with proven malignant fluids (∼5.5 months). Tumor genotype techniques are feasible on pleural fluid specimens and clinically helpful in identifying patients who may benefit from targeted therapies. If limited pleural involvement is detected during lung cancer surgery despite the presurgical imaging studies, macroscopic complete resection of the lung tumor is still a treatment option. Cytological examination for cancer cells in pleural cavity washings at the time of thoracotomy (pleural lavage cytology) is recommended to uncover pleural dissemination. Patients with non-small cell lung cancer with visceral pleural invasion might be considered candidates for postsurgical adjuvant therapy. Some predictors of adverse survival in patients with lung cancer include the presence of a minimal pleural effusion, positive pleural lavage cytology, visceral pleural invasion on pathologic examination, and unexpected pleural involvement during surgery.Keywords
This publication has 29 references indexed in Scilit:
- The IASLC Lung Cancer Staging ProjectJournal of Thoracic Oncology, 2015
- The diagnosis of pleural effusionsExpert Review of Respiratory Medicine, 2015
- TTF‐1 and napsin A on cell blocks and supernatants of pleural fluids for labeling malignant effusionsRespirology, 2015
- Clinical features and survival of lung cancer patients with pleural effusionsRespirology, 2015
- ARMS for EGFR mutation analysis of cytologic and corresponding lung adenocarcinoma histologic specimensJournal of Cancer Research and Clinical Oncology, 2014
- Etiología del derrame pleural: análisis de más de 3.000 toracocentesis consecutivasArchivos de Bronconeumología, 2014
- Prognostic Impact of Minimal Pleural Effusion in Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2014
- Malignant Pleural Effusion Supernatants Are Substitutes for Metastatic Pleural Tumor Tissues in EGFR Mutation Test in Patients with Advanced Lung AdenocarcinomaPLOS ONE, 2014
- Detection and comparison of EGFR mutations in matched tumor tissues, cell blocks, pleural effusions, and sera from patients with NSCLC with malignant pleural effusion, by PNA clamping and direct sequencingLung Cancer, 2013
- EGFR mutations in malignant pleural effusions from lung cancerCurrent Pulmonology Reports, 2013